You are here: Home » PTI Stories » National » News
Business Standard

PIL in HC for fixing price of stents

Press Trust of India  |  New Delhi 

A plea for fixing price of stents, used to treat narrowed or weakened arteries in the body, has been moved in the High Court, contending that the rate of the medical device has not been fixed despite it being included in the national essential list of medicines (NLEM).

The matter was listed for hearing before Justice Sanjeev Sachdeva who transferred it to the bench dealing with PILs as the has issues pertaining to general public interest.



As per the (PIL), moved by a lawyer, despite a July 19, 2016 notification by the Ministry of Health and Family Welfare deciding to include coronary stents in the NLEM 2015, its price has not yet been fixed.

The petitioner, Birender Sangwan, has claimed that the government and the National Pharmaceutical Pricing Authority (NPPA) are being "insensitive and irresponsible" towards the people by not taking any steps to fix the price of the medical device which is allegedly being sold at expensive rates in the country.

He has claimed that people in all age groups in the country suffer from heart ailments requiring use of stents and not all of them can afford this treatment.

He has sought a direction to the NPPA "to control the rate and decide a particular maximum retail price (MRP) of the coronary stents".

The also seeks a direction to the Drug Controller General of India "for providing prompt availability of the coronary stents at medical stores to enable patients to have a quick access to it".

Sangwan, represented by advocate Joginder Sukhija, has also said that it should be made mandatory to mention the MRP of the stents on the boxes containing these and to impose heavy penalty for not doing so.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

PIL in HC for fixing price of stents

A plea for fixing price of stents, used to treat narrowed or weakened arteries in the body, has been moved in the Delhi High Court, contending that the rate of the medical device has not been fixed despite it being included in the national essential list of medicines (NLEM). The matter was listed for hearing before Justice Sanjeev Sachdeva who transferred it to the bench dealing with PILs as the petition has issues pertaining to general public interest. As per the public interest litigation (PIL), moved by a lawyer, despite a July 19, 2016 notification by the Ministry of Health and Family Welfare deciding to include coronary stents in the NLEM 2015, its price has not yet been fixed. The petitioner, Birender Sangwan, has claimed that the government and the National Pharmaceutical Pricing Authority (NPPA) are being "insensitive and irresponsible" towards the people by not taking any steps to fix the price of the medical device which is allegedly being sold at expensive rates in the ... A plea for fixing price of stents, used to treat narrowed or weakened arteries in the body, has been moved in the High Court, contending that the rate of the medical device has not been fixed despite it being included in the national essential list of medicines (NLEM).

The matter was listed for hearing before Justice Sanjeev Sachdeva who transferred it to the bench dealing with PILs as the has issues pertaining to general public interest.

As per the (PIL), moved by a lawyer, despite a July 19, 2016 notification by the Ministry of Health and Family Welfare deciding to include coronary stents in the NLEM 2015, its price has not yet been fixed.

The petitioner, Birender Sangwan, has claimed that the government and the National Pharmaceutical Pricing Authority (NPPA) are being "insensitive and irresponsible" towards the people by not taking any steps to fix the price of the medical device which is allegedly being sold at expensive rates in the country.

He has claimed that people in all age groups in the country suffer from heart ailments requiring use of stents and not all of them can afford this treatment.

He has sought a direction to the NPPA "to control the rate and decide a particular maximum retail price (MRP) of the coronary stents".

The also seeks a direction to the Drug Controller General of India "for providing prompt availability of the coronary stents at medical stores to enable patients to have a quick access to it".

Sangwan, represented by advocate Joginder Sukhija, has also said that it should be made mandatory to mention the MRP of the stents on the boxes containing these and to impose heavy penalty for not doing so.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

PIL in HC for fixing price of stents

A plea for fixing price of stents, used to treat narrowed or weakened arteries in the body, has been moved in the High Court, contending that the rate of the medical device has not been fixed despite it being included in the national essential list of medicines (NLEM).

The matter was listed for hearing before Justice Sanjeev Sachdeva who transferred it to the bench dealing with PILs as the has issues pertaining to general public interest.

As per the (PIL), moved by a lawyer, despite a July 19, 2016 notification by the Ministry of Health and Family Welfare deciding to include coronary stents in the NLEM 2015, its price has not yet been fixed.

The petitioner, Birender Sangwan, has claimed that the government and the National Pharmaceutical Pricing Authority (NPPA) are being "insensitive and irresponsible" towards the people by not taking any steps to fix the price of the medical device which is allegedly being sold at expensive rates in the country.

He has claimed that people in all age groups in the country suffer from heart ailments requiring use of stents and not all of them can afford this treatment.

He has sought a direction to the NPPA "to control the rate and decide a particular maximum retail price (MRP) of the coronary stents".

The also seeks a direction to the Drug Controller General of India "for providing prompt availability of the coronary stents at medical stores to enable patients to have a quick access to it".

Sangwan, represented by advocate Joginder Sukhija, has also said that it should be made mandatory to mention the MRP of the stents on the boxes containing these and to impose heavy penalty for not doing so.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard